Among the casualties of the COVID-19 pandemic: the credibility of government agencies entrusted with protecting public health.
The FDA this week granted emergency use authorization for convalescent plasma as a treatment for infection by the novel coronavirus. FDA Commissioner Stephen Hahn and Department of Health and Human Services Secretary Alez Azar both misrepresented the magnitude of benefit shown in the clinical data used to justify the decision. Public health officials have said more rigorous testing is needed to understand just how useful the treatment could be.
Hahn tried to walk back some of his comments but the FDA wasn’t the… Read more »
UNDERWRITERS AND PARTNERS
